Moderna, Inc. against Teva Pharmaceutical Industries Limited — live side-by-side technical comparison.
Prices as of 2026-10-13T20:00:01+00:00 UTC · updates daily
MRNA leads 5 of the 5 windows we measure — over 1 month MRNA is +50.2% and TEVA +11.2%; over year to date MRNA is +633.3% and TEVA +32.2%. The MRNA/TEVA price ratio stands at 5.2424, above its 50-day average of 3.7752, and above the 200-day average of 2.1184. A ratio above its own average means MRNA is gaining on TEVA; on this reading the recent edge belongs to MRNA.
| MRNA | TEVA | |
|---|---|---|
| Price | $216.25 | $41.25 |
| 1 day | +1.2%lead | +0.2% |
| 5 days | +15.4%lead | +5.4% |
| 1 month | +50.2%lead | +11.2% |
| 6 months | +326.7%lead | +32.4% |
| Year to date | +633.3%lead | +32.2% |
| 52-week position | 95% of range | 97% of range |
| 52-week range | $22.28–$227.46 | $18.83–$42.02 |
| vs 50-day average | above $144.66 | above $37.88 |
| vs 200-day average | above $74.46 | above $34.01 |
| RSI (14) | 64 | 66 |
| Next earnings | 2026-11-06 | 2026-11-03 |
MRNA trades at $216.25, above its 50-day average of $144.66, and above the 200-day at $74.46. It sits at 95% of its 52-week range ($22.28–$227.46); 14-day RSI is 64, in neutral territory; an average session moves it about 7.4%. For levels, the first level overhead is $225.00 (4.0% away) and the first support below is $200.00 (7.5% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
TEVA trades at $41.25, above its 50-day average of $37.88, and above the 200-day at $34.01. It sits at 97% of its 52-week range ($18.83–$42.02); 14-day RSI is 66, in neutral territory; an average session moves it about 2.9%. For levels, the first level overhead is $45.00 (9.1% away) and the first support below is $40.00 (3.0% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
MRNA is the more volatile of the two — an average session moves it 7.4% against 2.9% for TEVA, so an identical position size carries roughly 2.6× the daily risk.
The comparison turns on those levels: MRNA clearing $225.00 or losing $200.00; TEVA clearing $45.00 or losing $40.00. Until one of them gives way, the relative reading above stands.